Cancer Care Northwest-South

Spokane, Washington 99202

0 studies enrolling now · 12 studies all time

What they study most

Androgen-independent Prostate Cancer, B-Cell Chronic Lymphocytic Leukemia, Breast Cancer, Gastric Cancer Adenocarcinoma Metastatic, Mantle Cell Lymphoma, Metastatic Breast Cancer, Metastatic Colorectal Cancer, Non-Hodgkin's Lymphoma, Ovarian Cancer, Rectal Cancer, Small Cell Lung Cancer

Studies at this site

• Tarlatamab (AMG 757) Expanded Access Protocol for Advanced Small Cell Lung Cancer — APPROVED_FOR_MARKETING
• PhII ICb With/Without Erbitux in MBC Pts — Running, not enrolling
• TAC Versus TC for Adjuvant Breast Cancer — Completed
• Efficacy and Safety of Farletuzumab (MORAb-003) in Combination With Carboplatin and Taxane in Participants With Platinum-sensitive Ovarian Cancer in First Relapse — Stopped early
• A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer — Completed
• Cetuximab, Bevacizumab & 5FU/Leucovorin vs. Oxaliplatin, Bevacizumab & 5FU/Leucovorin in Metastatic Colorectal Cancer — Completed
• Mitoxantrone ± Cetuximab 2nd Line Androgen Independent Prostate Cancer (AIPC) — Completed
• Docetaxel+Oxali+/-Cetux Met Gastric/GEJ — Completed
• Fludarabine, Cyclophosphamide, and Rituximab Versus Pentostatin, Cyclophosphamide, and Rituximab in Previously Untreated or Treated B-Cell Chronic Lymphocytic Leukemia Patients — Completed
• Pre-op Rectal ChemoRad +/- Cetuximab — Completed
• Adj TC + Herceptin Early Stage Breast Cancer — Completed
• Study to Assess the Effect of Treatment With Bendamustine in Combination With Rituximab on QT Interval in Patients With Advanced Indolent Non-Hodgkin's Lymphoma (NHL) or Mantle Cell Lymphoma (MCL) — Completed